What is Endobloc 5mg (ENZALUTAMIDE)?
Androgen receptor inhibitor for castration-resistant prostate cancer (CRPC) — both non-metastatic and metastatic, and metastatic castration-sensitive prostate cancer (mCSPC).
How it Works
Blocks androgen receptor (AR) signaling at multiple steps: prevents androgen binding, AR nuclear translocation, and AR-DNA interaction. More potent than first-generation anti-androgens.
Quick Specs
- Form
- Oral tablets — pre-dosed
- Active Ingredient
- ENZALUTAMIDE
- Dose per Tablet
- 5MG
- Pack Size
- 10×10 (100 tablets)
- Storage
- Room temperature (15–25°C), cool dry place
- Shelf Life
- 2–3 years (properly stored)
Common Side Effects
Fatigue (most common), hot flushes, hypertension, seizures (<1% risk), fall/fractures, cognitive effects, QT prolongation.
Safety Warnings
Seizure risk — avoid in patients with history of seizures. Falls and fractures — bone protection. CYP3A4 and CYP2C8 inducer — reduces levels of many medications. Embryofetal toxicity. International shipping: 7–14 days